Ask the Editor: The Effect of Sample Diluent Ionic Strength
What is the effect of sample diluent ionic strength?
The following question and answer are taken from LCGC Europe's "CE Currents" column (1).
What is the effect of sample diluent ionic strength?
In capillary electrophoresis (CE) the typical length of an injection inside the capillary is a few millimeters. This is a significant length given that the total capillary length may be 30 cm and the detection window may be 0.1 mm. The peak width is directly related to the injection zone length. Ideally the injection zone length would be very small but this would result in sensitivity issues.
There are many different in-capillary concentration approaches in CE that can be used to improve method sensitivity and separation efficiency by reducing peak width after injection. These have been summarized and interested readers should read these more in-depth publications (2,3).
The most common approach to reducing the zone length of the sample injection is by using a process termed "stacking." Stacking reduces the width of the sample zone at the start of the separation when the voltage is initially applied and results in an improved sensitivity (because the sample becomes more concentrated inside the capillary) and increased peak efficiency.
(1) K. Altria, LCGC Europe, April 2008.
(2) Z.K. Shihabi, J. Chromatogr. A 902(1), 107-117 (2000).
(3) M.C. Breadmore, Electrophoresis 28(1-2), 254-281 (2007).
Questions?
LCGC technical editor Steve Brown will answer your technical questions. Each month, one question will be selected to appear in this space, so we welcome your submissions. Please send all questions to the attention of "Ask the Editor" at lcgcedit@lcgcmag.com We look forward to hearing from you.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
